Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI

By Erem Cihangir  

Endocrine Journal, Vol. 33, Iss. 3, 2008-06 ,pp. : 270-276

Humana Press, Inc

Access to resources Recommend Favorite

Structural Requirements of Human Tissue Factor Pathway Inhibitor (TFPI) and Heparin for TFPI-Heparin Interaction - Proposed heparin recognition region

By Ye Z.   Takano R.   Hayashi K.   Ta T.-V.   Kato H.   Kamikubo Y.   Nakahara Y.   Kumeda K.   Hara S.  

Thrombosis Research, Vol. 89, Iss. 6, 1998-03 ,pp. : 263-270

Elsevier

Access to resources Recommend Favorite

Plasma Tissue Factor Pathway Inhibitor and Tissue Factor Antigen Levels After Administration of Heparin in Patients With Angina Pectoris - Relationship between free and endothelial cell-associated forms of TFPI

By Soejima H.   Ogawa H.   Yasue H.   Nishiyama K.   Kaikita K.   Misumi K.   Takazoe K.   Kugiyama K.   Tsuji I.   Kumeda K.   Nakamura S.  

Thrombosis Research, Vol. 93, Iss. 1, 1999-01 ,pp. : 17-25

Elsevier

Access to resources Recommend Favorite

Inhibitory Properties of Human Recombinant Arg 24 ->Gln Type-2 Tissue Factor Pathway Inhibitor (R24Q TFPI-2) - The relationship between intermolecular association with factor VIIa and enzymatic activity of the complex

By Kamei S.   Petersen L.C.   Sprecher C.A.   Foster D.C.   Kisiel W.  

Thrombosis Research, Vol. 94, Iss. 3, 1999-05 ,pp. : 147-152

Elsevier

Access to resources Recommend Favorite

Low levels of tissue factor pathway inhibitor (TFPI) in two out of three members of a family with thrombophilia.

By Llobet D.   Falkon L.   Mateo J.   Vallve C.   Martinez E.   Fontcuberta J.   Borrell M.  

Thrombosis Research, Vol. 80, Iss. 5, 1995-12 ,pp. : 413-418

Elsevier

Access to resources Recommend Favorite